Reuters exclusively reports PAI Partners close to acquiring France’s SGD Pharma

Reuters reported exclusively that private equity firm PAI Partners is in final talks to buy France’s SGD Pharma, a firm […] The post Reuters exclusively reports PAI Partners close to acquiring France’s SGD Pharma appeared first on Reuters News Agency.

Reuters exclusively reports PAI Partners close to acquiring France’s SGD Pharma

Reuters reported exclusively that private equity firm PAI Partners is in final talks to buy France’s SGD Pharma, a firm that makes the vials used to store COVID-19 vaccines. According to a Reuters source, the transaction was expected to value SGD Pharma at around 10 times its core earnings, which stood at approximately 90 million euros ($109.15 million) last year. The deal was officially announced nine hours after the Reuters report was published. 

The post Reuters exclusively reports PAI Partners close to acquiring France’s SGD Pharma appeared first on Reuters News Agency.